Stay updated with breaking news from Absci Founder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leading AI biologics and precision medicine innovators will harness technologies to build a diverse portfolio of novel drug treatments
Leading AI biologics and precision medicine innovators will harness technologies to build a diverse portfolio of novel drug treatments With this partnership, Absci achieves 2023 outlook of ten...
Absci and PrecisionLife partner to develop an AI-enabled drug pipeline of novel biotherapeutics leveraging Absci's AI and PrecisionLife's...
Collaboration Combines Absci’s AI Antibody Drug Creation Platform with AstraZeneca’s Expertise in Oncology Research and DevelopmentVANCOUVER, Wash., Dec. 04, 2023 -- Absci Corporation , a...
Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on medical dermatology, and Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating ...